Proteome Sciences Pl (PMSNF) 0.2870 $PMSNF
Global Infectious Disease Molecular Diagnostics Market 2015 - Five-year Test Volume and Sales Forecasts
M2 - Thu Aug 13, 10:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kj4b26/2015_global) has announced the addition of the "2015 Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies and Competitive Landscape" report to their offering. This new seven-country study contains 1,265 pages, 191 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Rationale The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forenciscs/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion For more information visit http://www.researchandmarkets.com/research/kj...015_global
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
Global Automated Microbiology Market 2015-2019 - Examines Key Trends in the U.S, Five Major European Countries and Japan
M2 - Wed Aug 12, 9:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8mmngn/20152019_global) has announced the addition of the "2015-2019 Global Automated Microbiology Market: US, Europe, Japan--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Emerging Opportunities for Instrument and Reagent Suppli" report to their offering. 2015-2019 Global Automated Microbiology Market: US, Europe, Japan is a new seven-countrystrategic analysis of the major business opportunities emerging in the automated microbiology market during the nextfive years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale - The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. - The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. The companies analyzed in the report include - Abbott, - Affymetrix, - Agilent Technologies, - Arca Biopharma, - Beckman Coulter/Danaher, - Becton Dickinson, - Biokit, - bioMerieux, - Bio-Rad, - Biotest, - Cepheid, - CellMark Forensics/LabCorp, - Decode Genetics, - Diadexus, - Diamedix, - DiaSorin, - Eiken Chemical, - Elitech Group, - Enzo Biochem, - Exact Sciences, - Fujirebio, - Grifols, - Hologic/Gen-Probe, - Illumina, - ID Biomedical/GSK, - Kreatech Leica, Li-Cor Biosciences, - Lonza, Monogram Biosciences, - Myriad Genetics, - Ortho-Clinical Diagnostics, - Perkin Elmer/Caliper, - Proteome Sciences, - Qiagen, - Roche For more information visit http://www.researchandmarkets.com/research/8m...019_global
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
France Automated Microbiology Market 2015-2019 - Examines Key Trends, Reviews Current and Emerging Assays
M2 - Wed Aug 12, 8:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rdfkgm/20152019_france) has announced the addition of the "2015-2019 France Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Emerging Opportunities for Instrument and Reagent Suppliers--Competitive St" report to their offering. 2015-2019 France Automated Microbiology Market is a new analysis of major business opportunities emerging in the French automated microbiology market during the nextfive years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The companies analyzed in the report include - Abbott, - Affymetrix, - Agilent Technologies, - Arca Biopharma, - Beckman Coulter/Danaher, - Becton Dickinson, - Biokit, - bioMerieux, - Bio-Rad, - Biotest, - Cepheid, - CellMark Forensics/LabCorp, - Decode Genetics, Diadexus, - Diamedix, - DiaSorin, - Eiken Chemical, - Elitech Group, - Enzo Biochem, - Exact Sciences, - Fujirebio, - Grifols, - Hologic/Gen-Probe, - Illumina, - ID Biomedical/GSK, - Kreatech/Leica, - Li-Cor Biosciences, - Lonza, Monogram Biosciences, - Myriad Genetics, - Ortho-Clinical Diagnostics, - Perkin Elmer/Caliper, - Proteome Sciences, - Qiagen, - Roche, For more information visit http://www.researchandmarkets.com/research/rd...019_france
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 Germany Automated Microbiology Market - Volume and Sales Forecasts for Over 100 Infectious Disease Assays by Individual Test
M2 - Wed Aug 12, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tsqljg/20152019_germany) has announced the addition of the "2015-2019 Germany Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Emerging Opportunities for Instrument and Reagent Suppliers--Competitive S" report to their offering. 2015-2019 Germany Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics 2015-2019 Germany Automated Microbiology Market is a new analysis of major business opportunities emerging in the German automated microbiology market during the nextfive years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Market Segmentation Analysis - Sales and market shares for major suppliers by individual test. - Volume and sales forecasts for over 100 infectious disease assays by individual test: - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). The companies analyzed in the report include - Abbott, - Affymetrix, - Agilent Technologies, - Arca Biopharma, - Beckman - Coulter/Danaher, - Becton Dickinson, - Biokit, bioMerieux, - Bio-Rad, - Biotest, - Cepheid, - CellMark Forensics/LabCorp, - Decode Genetics, - Diadexus, - Diamedix, - DiaSorin, - Eiken Chemical, - Elitech Group, - Enzo Biochem, - Exact Sciences, - Fujirebio, - Grifols, - Hologic/Gen-Probe, - Illumina, - ID Biomedical/GSK, - Kreatech/Leica, - Li-Cor Biosciences, - Lonza, - Monogram Biosciences, - Myriad Genetics, - Ortho-Clinical Diagnostics, - Perkin Elmer/Caliper, - Proteome Sciences, - Qiagen, - Roche, - Scienion, For more information visit http://www.researchandmarkets.com/research/ts...19_germany
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), HOLX: 40.11 (+0.72)
Italy Automated Microbiology Market 2015-2019 - Examines Key Trends, Reviews Current and Emerging Assays
M2 - Wed Aug 12, 6:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vpwv26/20152019_italy) has announced the addition of the "2015-2019 Italy Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Emerging Opportunities for Instrument and Reagent Suppliers--Competitive Str" report to their offering. 2015-2019 Italy Automated Microbiology Market is a new analysis of major business opportunities emerging in the Italian automated microbiology market during the nextfive years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale - The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. - The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. - The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The companies analyzed in the report include - Abbott, - Affymetrix, - Agilent Technologies, - Arca Biopharma, - Beckman Coulter/Danaher, - Becton Dickinson, - Biokit, - bioMerieux, - Bio-Rad, - Biotest, - Cepheid, - CellMark - Forensics/LabCorp, - Decode Genetics, - Diadexus, Diamedix, - DiaSorin, - Eiken Chemical, - Elitech Group, - Enzo Biochem, - Exact Sciences, - Fujirebio, - Grifols, - Hologic/Gen-Probe, - Illumina, - ID Biomedical/GSK, - Kreatech/Leica, - Li-Cor Biosciences, - Lonza, - Monogram Biosciences, - Myriad Genetics, - Ortho-Clinical Diagnostics, - Perkin Elmer/Caliper, - Proteome Sciences, - Qiagen For more information visit http://www.researchandmarkets.com/research/vp...2019_italy
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts
PR Newswire Europe - Mon Aug 10, 11:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pdhqcr/20152019_global [http://www.researchandmarkets.com/research/pdhqcr/20152019_global]) has announced the addition of the "2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts" [http://www.researchandmarkets.com/research/pdhqcr/20152019_global] report to their offering.
DHR: 86.84 (+0.79)
2015-2019 Global Transfusion Diagnostic Testing Market - Presents Analyses of Leading Current and Emerging Suppliers
M2 - Mon Aug 10, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z4c75f/20152019_global) has announced the addition of the "2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts" report to their offering. 2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts This report provides a worldwide overview of the Transfusion Diagnostic Testing market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. The report also presents analyses of leading current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Table of Contents 1. Worldwide Business Environment 2. Worldwide Market Structure 3. Worldwide Market Size and Growth 4. Competitive Assessments: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Gen-Probe - Grifols - Immucor - Ortho-Clinical Diagnostics - Proteome Sciences - Roche - Siemens - Tecan List of Tables Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country Worldwide, All Market Segments, Blood Typing and Grouping Test Volume Forecast By Country Worldwide, All Market Segments, Infectious Disease Screening Test Volume Forecast By Country Worldwide, All Market Segments, Blood Typing and Grouping Reagent Market Forecast By Country Worldwide, All Market Segments, Infectious Disease Screening Reagent Market Forecast By Country For more information visit http://www.researchandmarkets.com/research/z4...019_global
DHR: 86.84 (+0.79)
US Automated Microbiology Market 2015-2019 - Competitive Strategies, Supplier Shares, Country Segment Forecasts, Innovative Technologies & Instrumentation Review
M2 - Fri Aug 07, 3:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dw5rs/20152019_us) has announced the addition of the "2015-2019 US Automated Microbiology Market--Competitive Strategies, Supplier Shares, Country Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. 2015-2019 US Automated Microbiology Market is a new analysis of major business opportunities emerging in the US automated microbiology market during the nextfive years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide. This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding US microbiology market, in evaluating emerging opportunities and developing effective business strategies. The companies analyzed in the report include: - Abbott - Affymetrix - Agilent Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Diamedix/Erba - DiaSorin - Eiken Chemical - Elitech Group - Enzo Biochem - Exact Sciences - Fujirebio - Girfols - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech/Leica - Li-Cor Biosciences - Lonza - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche For more information visit http://www.researchandmarkets.com/research/9d...0152019_us
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
US Molecular Diagnostic Product Suppliers 2015 - Sales and Market Shares by Test
M2 - Fri Aug 07, 3:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xh664j/2015_us_molecular) has announced the addition of the "2015 US Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test" report to their offering. This unique report provides US Sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/xh..._molecular
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79)
2015 New Frontiers in the US Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape
M2 - Thu Aug 06, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9drn4k/2015_new) has announced the addition of the "2015 New Frontiers in the US Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape" report to their offering. 2015 New Frontiers in the US Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape is a new analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the US automated microbiology market; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide. This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Pharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad- - Biotest - Cepheid - CellMark Forenciscs/Lab Corp - Decode Genetics - Diadexus - Diamedix - DiaSorin - Eiken Chemical - Elitech Group - Enzo Biochem - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech/Leica - Li-Cor Biosciences - Lonza - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Sierra Molecular - Shimadzu - Takara Bio - Tecan - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/9drn4k/2015_new
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), DHR: 86.84 (+0.79), SQNM: 2.13 (-0.03), ENZ: 3.04 (-0.03), CPHD: 51.97 (+0.70), HOLX: 40.11 (+0.72)
2015 US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Thu Aug 06, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jf2lnb/2015_us_sales_and) has announced the addition of the "2015 US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides US sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher List of Tables - U.S.A., Major Suppliers of Blood Typing and Grouping Reagents Sales and Market Shares - U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier - U.S.A., Hepatitis C Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales by Major Supplier - U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier - U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier Contains 87 pages and 8 tables For more information visit http://www.researchandmarkets.com/research/jf..._sales_and
DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 France Infectious Disease Molecular Diagnostics Market - Strategic Profiles of Leading Market Players and Start-up Firms Developing Innovative Products
M2 - Wed Aug 05, 9:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r8jv5h/20152019_france) has announced the addition of the "2015-2019 France Infectious Disease Molecular Diagnostics Market: Emerging Opportunities and Growth Strategies for Suppliers--Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new study contains 980 pages, 55 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D. Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/r8...019_france
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 Germany Infectious Disease Molecular Diagnostics Market - Strategic Profiles of Leading Market Players and Start-Up Firms Developing Innovative Products
M2 - Wed Aug 05, 9:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gcfbrc/20152019_germany) has announced the addition of the "2015-2019 Germany Infectious Disease Molecular Diagnostics Market: Emerging Opportunities and Growth Strategies for Suppliers--Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new study contains 980 pages, 55 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D. - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forenciscs/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/gc...19_germany
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
United States Infectious Disease Molecular Diagnostics Market 2015-2019: Emerging Opportunities and Growth Strategies for Suppliers
M2 - Tue Aug 04, 8:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zkr89z/20152019_us) has announced the addition of the "2015-2019 US Infectious Disease Molecular Diagnostics Market: Emerging Opportunities and Growth Strategies for Suppliers--Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. This new study contains 1,013 pages, 62 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/zk...0152019_us
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
Global Infectious Disease Molecular Diagnostics Market 2015-2019: Emerging Opportunities and Growth Strategies for Suppliers
M2 - Wed Jul 29, 11:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xszz24/20152019_global) has announced the addition of the "2015-2019 Global Infectious Disease Molecular Diagnostics Market: Emerging Opportunities and Growth Strategies for Suppliers--Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. This new seven-country study contains 1,265 pages, 191 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/xs...019_global
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
Global Infectious Disease Molecular Diagnostics Market 2015: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
M2 - Wed Jul 29, 6:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kkvb5t/2015_global) has announced the addition of the "2015 Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry.The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new seven-country study contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Pharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forenciscs/LabCorp - DecodeGenetics - Diadexus - Eiken - Elitech Group - Enzo - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kk...015_global
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
US Nucleic Acid Testing/NAT Market 2015-2019: Sales and Market Shares of Major Suppliers
M2 - Mon Jul 20, 9:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/brtn3w/20152019_us) has announced the addition of the "2015-2019 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom For more information visit http://www.researchandmarkets.com/research/br...0152019_us
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
US Molecular Diagnostics Market 2015-2019 - Sales and Market Shares of Major Suppliers
M2 - Mon Jul 20, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9x3trk/20152019_us) has announced the addition of the "2015-2019 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Eiken - Elitech Group - Enzo - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/9x...0152019_us
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets
M2 - Fri Jul 10, 10:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kx789r/20152019_u_s) has announced the addition of the "2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others - A comprehensive analysis of the sequencing market by laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of the major molecular diagnosticanalyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom For more information visit http://www.researchandmarkets.com/research/kx...152019_u_s
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
World Infectious Disease Molecular Diagnostics Market 2015-2019
M2 - Thu Jul 09, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4c7sd/20152019_world) has announced the addition of the "2015-2019 World Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Grifols - Hologic/Gen-Probe Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/c4...2019_world
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), DHR: 86.84 (+0.79), SQNM: 2.13 (-0.03), CPHD: 51.97 (+0.70), HOLX: 40.11 (+0.72)
Global Infectious Disease Molecular Diagnostics Market 2015 - Five-year Test Volume and Sales Forecasts
M2 - Thu Aug 13, 10:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kj4b26/2015_global) has announced the addition of the "2015 Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies and Competitive Landscape" report to their offering. This new seven-country study contains 1,265 pages, 191 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Rationale The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forenciscs/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion For more information visit http://www.researchandmarkets.com/research/kj...015_global
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
Global Automated Microbiology Market 2015-2019 - Examines Key Trends in the U.S, Five Major European Countries and Japan
M2 - Wed Aug 12, 9:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8mmngn/20152019_global) has announced the addition of the "2015-2019 Global Automated Microbiology Market: US, Europe, Japan--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Emerging Opportunities for Instrument and Reagent Suppli" report to their offering. 2015-2019 Global Automated Microbiology Market: US, Europe, Japan is a new seven-countrystrategic analysis of the major business opportunities emerging in the automated microbiology market during the nextfive years. The report examines key trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale - The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. - The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. The companies analyzed in the report include - Abbott, - Affymetrix, - Agilent Technologies, - Arca Biopharma, - Beckman Coulter/Danaher, - Becton Dickinson, - Biokit, - bioMerieux, - Bio-Rad, - Biotest, - Cepheid, - CellMark Forensics/LabCorp, - Decode Genetics, - Diadexus, - Diamedix, - DiaSorin, - Eiken Chemical, - Elitech Group, - Enzo Biochem, - Exact Sciences, - Fujirebio, - Grifols, - Hologic/Gen-Probe, - Illumina, - ID Biomedical/GSK, - Kreatech Leica, Li-Cor Biosciences, - Lonza, Monogram Biosciences, - Myriad Genetics, - Ortho-Clinical Diagnostics, - Perkin Elmer/Caliper, - Proteome Sciences, - Qiagen, - Roche For more information visit http://www.researchandmarkets.com/research/8m...019_global
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
France Automated Microbiology Market 2015-2019 - Examines Key Trends, Reviews Current and Emerging Assays
M2 - Wed Aug 12, 8:49AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rdfkgm/20152019_france) has announced the addition of the "2015-2019 France Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Emerging Opportunities for Instrument and Reagent Suppliers--Competitive St" report to their offering. 2015-2019 France Automated Microbiology Market is a new analysis of major business opportunities emerging in the French automated microbiology market during the nextfive years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The companies analyzed in the report include - Abbott, - Affymetrix, - Agilent Technologies, - Arca Biopharma, - Beckman Coulter/Danaher, - Becton Dickinson, - Biokit, - bioMerieux, - Bio-Rad, - Biotest, - Cepheid, - CellMark Forensics/LabCorp, - Decode Genetics, Diadexus, - Diamedix, - DiaSorin, - Eiken Chemical, - Elitech Group, - Enzo Biochem, - Exact Sciences, - Fujirebio, - Grifols, - Hologic/Gen-Probe, - Illumina, - ID Biomedical/GSK, - Kreatech/Leica, - Li-Cor Biosciences, - Lonza, Monogram Biosciences, - Myriad Genetics, - Ortho-Clinical Diagnostics, - Perkin Elmer/Caliper, - Proteome Sciences, - Qiagen, - Roche, For more information visit http://www.researchandmarkets.com/research/rd...019_france
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 Germany Automated Microbiology Market - Volume and Sales Forecasts for Over 100 Infectious Disease Assays by Individual Test
M2 - Wed Aug 12, 8:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tsqljg/20152019_germany) has announced the addition of the "2015-2019 Germany Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Emerging Opportunities for Instrument and Reagent Suppliers--Competitive S" report to their offering. 2015-2019 Germany Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics 2015-2019 Germany Automated Microbiology Market is a new analysis of major business opportunities emerging in the German automated microbiology market during the nextfive years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Market Segmentation Analysis - Sales and market shares for major suppliers by individual test. - Volume and sales forecasts for over 100 infectious disease assays by individual test: - Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). The companies analyzed in the report include - Abbott, - Affymetrix, - Agilent Technologies, - Arca Biopharma, - Beckman - Coulter/Danaher, - Becton Dickinson, - Biokit, bioMerieux, - Bio-Rad, - Biotest, - Cepheid, - CellMark Forensics/LabCorp, - Decode Genetics, - Diadexus, - Diamedix, - DiaSorin, - Eiken Chemical, - Elitech Group, - Enzo Biochem, - Exact Sciences, - Fujirebio, - Grifols, - Hologic/Gen-Probe, - Illumina, - ID Biomedical/GSK, - Kreatech/Leica, - Li-Cor Biosciences, - Lonza, - Monogram Biosciences, - Myriad Genetics, - Ortho-Clinical Diagnostics, - Perkin Elmer/Caliper, - Proteome Sciences, - Qiagen, - Roche, - Scienion, For more information visit http://www.researchandmarkets.com/research/ts...19_germany
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), HOLX: 40.11 (+0.72)
Italy Automated Microbiology Market 2015-2019 - Examines Key Trends, Reviews Current and Emerging Assays
M2 - Wed Aug 12, 6:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vpwv26/20152019_italy) has announced the addition of the "2015-2019 Italy Automated Microbiology Market: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Emerging Opportunities for Instrument and Reagent Suppliers--Competitive Str" report to their offering. 2015-2019 Italy Automated Microbiology Market is a new analysis of major business opportunities emerging in the Italian automated microbiology market during the nextfive years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale - The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. - The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. - The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The companies analyzed in the report include - Abbott, - Affymetrix, - Agilent Technologies, - Arca Biopharma, - Beckman Coulter/Danaher, - Becton Dickinson, - Biokit, - bioMerieux, - Bio-Rad, - Biotest, - Cepheid, - CellMark - Forensics/LabCorp, - Decode Genetics, - Diadexus, Diamedix, - DiaSorin, - Eiken Chemical, - Elitech Group, - Enzo Biochem, - Exact Sciences, - Fujirebio, - Grifols, - Hologic/Gen-Probe, - Illumina, - ID Biomedical/GSK, - Kreatech/Leica, - Li-Cor Biosciences, - Lonza, - Monogram Biosciences, - Myriad Genetics, - Ortho-Clinical Diagnostics, - Perkin Elmer/Caliper, - Proteome Sciences, - Qiagen For more information visit http://www.researchandmarkets.com/research/vp...2019_italy
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts
PR Newswire Europe - Mon Aug 10, 11:10AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pdhqcr/20152019_global [http://www.researchandmarkets.com/research/pdhqcr/20152019_global]) has announced the addition of the "2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts" [http://www.researchandmarkets.com/research/pdhqcr/20152019_global] report to their offering.
DHR: 86.84 (+0.79)
2015-2019 Global Transfusion Diagnostic Testing Market - Presents Analyses of Leading Current and Emerging Suppliers
M2 - Mon Aug 10, 9:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z4c75f/20152019_global) has announced the addition of the "2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts" report to their offering. 2015-2019 Global Transfusion Diagnostic Testing Market: US, Europe, Japan--Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts This report provides a worldwide overview of the Transfusion Diagnostic Testing market, including estimates of facilities performing blood banking tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country. The report also presents analyses of leading current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Table of Contents 1. Worldwide Business Environment 2. Worldwide Market Structure 3. Worldwide Market Size and Growth 4. Competitive Assessments: - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Gen-Probe - Grifols - Immucor - Ortho-Clinical Diagnostics - Proteome Sciences - Roche - Siemens - Tecan List of Tables Worldwide, All Market Segments, Facilities Performing Blood Bank Tests By Country Worldwide, All Market Segments, Blood Typing and Grouping Test Volume Forecast By Country Worldwide, All Market Segments, Infectious Disease Screening Test Volume Forecast By Country Worldwide, All Market Segments, Blood Typing and Grouping Reagent Market Forecast By Country Worldwide, All Market Segments, Infectious Disease Screening Reagent Market Forecast By Country For more information visit http://www.researchandmarkets.com/research/z4...019_global
DHR: 86.84 (+0.79)
US Automated Microbiology Market 2015-2019 - Competitive Strategies, Supplier Shares, Country Segment Forecasts, Innovative Technologies & Instrumentation Review
M2 - Fri Aug 07, 3:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9dw5rs/20152019_us) has announced the addition of the "2015-2019 US Automated Microbiology Market--Competitive Strategies, Supplier Shares, Country Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. 2015-2019 US Automated Microbiology Market is a new analysis of major business opportunities emerging in the US automated microbiology market during the nextfive years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. Rationale The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon. The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide. This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding US microbiology market, in evaluating emerging opportunities and developing effective business strategies. The companies analyzed in the report include: - Abbott - Affymetrix - Agilent Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Diamedix/Erba - DiaSorin - Eiken Chemical - Elitech Group - Enzo Biochem - Exact Sciences - Fujirebio - Girfols - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech/Leica - Li-Cor Biosciences - Lonza - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche For more information visit http://www.researchandmarkets.com/research/9d...0152019_us
MYGN: 38.46 (+0.07), ENZ: 3.04 (-0.03), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
US Molecular Diagnostic Product Suppliers 2015 - Sales and Market Shares by Test
M2 - Fri Aug 07, 3:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xh664j/2015_us_molecular) has announced the addition of the "2015 US Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test" report to their offering. This unique report provides US Sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/xh..._molecular
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79)
2015 New Frontiers in the US Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape
M2 - Thu Aug 06, 9:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9drn4k/2015_new) has announced the addition of the "2015 New Frontiers in the US Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape" report to their offering. 2015 New Frontiers in the US Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape is a new analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the US automated microbiology market; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers. The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide. This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Pharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad- - Biotest - Cepheid - CellMark Forenciscs/Lab Corp - Decode Genetics - Diadexus - Diamedix - DiaSorin - Eiken Chemical - Elitech Group - Enzo Biochem - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - ID Biomedical/GSK - Kreatech/Leica - Li-Cor Biosciences - Lonza - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - SeraCare - Siemens - Sierra Molecular - Shimadzu - Takara Bio - Tecan - Thermo Fisher - Wallac/PE - Wako For more information visit http://www.researchandmarkets.com/research/9drn4k/2015_new
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), DHR: 86.84 (+0.79), SQNM: 2.13 (-0.03), ENZ: 3.04 (-0.03), CPHD: 51.97 (+0.70), HOLX: 40.11 (+0.72)
2015 US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test
M2 - Thu Aug 06, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jf2lnb/2015_us_sales_and) has announced the addition of the "2015 US Sales and Market Shares of Major Blood Typing, Grouping and Infectious Disease Screening Product Suppliers by Test" report to their offering. This unique report provides US sales and market share estimates for major suppliers of blood typing, grouping and infectious disease screening products by test. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Grifols - Hologic/Gen-Probe - Immucor - Ortho-Clinical Diagnostic - Proteome Sciences - Quest - Quidel - Roche - Siemens - Tecan - Thermo Fisher List of Tables - U.S.A., Major Suppliers of Blood Typing and Grouping Reagents Sales and Market Shares - U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier - U.S.A., Hepatitis C Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales by Major Supplier - U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier - U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier - U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier Contains 87 pages and 8 tables For more information visit http://www.researchandmarkets.com/research/jf..._sales_and
DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 France Infectious Disease Molecular Diagnostics Market - Strategic Profiles of Leading Market Players and Start-up Firms Developing Innovative Products
M2 - Wed Aug 05, 9:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r8jv5h/20152019_france) has announced the addition of the "2015-2019 France Infectious Disease Molecular Diagnostics Market: Emerging Opportunities and Growth Strategies for Suppliers--Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new study contains 980 pages, 55 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D. Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/r8...019_france
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 Germany Infectious Disease Molecular Diagnostics Market - Strategic Profiles of Leading Market Players and Start-Up Firms Developing Innovative Products
M2 - Wed Aug 05, 9:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gcfbrc/20152019_germany) has announced the addition of the "2015-2019 Germany Infectious Disease Molecular Diagnostics Market: Emerging Opportunities and Growth Strategies for Suppliers--Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new study contains 980 pages, 55 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D. - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forenciscs/LabCorp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/gc...19_germany
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
United States Infectious Disease Molecular Diagnostics Market 2015-2019: Emerging Opportunities and Growth Strategies for Suppliers
M2 - Tue Aug 04, 8:12AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zkr89z/20152019_us) has announced the addition of the "2015-2019 US Infectious Disease Molecular Diagnostics Market: Emerging Opportunities and Growth Strategies for Suppliers--Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. This new study contains 1,013 pages, 62 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/zk...0152019_us
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
Global Infectious Disease Molecular Diagnostics Market 2015-2019: Emerging Opportunities and Growth Strategies for Suppliers
M2 - Wed Jul 29, 11:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xszz24/20152019_global) has announced the addition of the "2015-2019 Global Infectious Disease Molecular Diagnostics Market: Emerging Opportunities and Growth Strategies for Suppliers--Competitive Strategies, Supplier Shares, Segment Forecasts, Innovative Technologies, Instrumentation Review" report to their offering. This new seven-country study contains 1,265 pages, 191 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/xs...019_global
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
Global Infectious Disease Molecular Diagnostics Market 2015: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
M2 - Wed Jul 29, 6:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kkvb5t/2015_global) has announced the addition of the "2015 Global Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry.The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. This new seven-country study contains 775 pages, 73 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Pharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forenciscs/LabCorp - DecodeGenetics - Diadexus - Eiken - Elitech Group - Enzo - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kk...015_global
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
US Nucleic Acid Testing/NAT Market 2015-2019: Sales and Market Shares of Major Suppliers
M2 - Mon Jul 20, 9:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/brtn3w/20152019_us) has announced the addition of the "2015-2019 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom For more information visit http://www.researchandmarkets.com/research/br...0152019_us
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
US Molecular Diagnostics Market 2015-2019 - Sales and Market Shares of Major Suppliers
M2 - Mon Jul 20, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9x3trk/20152019_us) has announced the addition of the "2015-2019 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics/LabCorp - Decode Genetics - Eiken - Elitech Group - Enzo - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/9x...0152019_us
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets
M2 - Fri Jul 10, 10:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kx789r/20152019_u_s) has announced the addition of the "2015-2019 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies" report to their offering. Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. Report Highlights - Market shares of leading suppliers - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. U.S. Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment. - Five-year test volume and sales projections. Market Segmentation Analysis - Five-year test volume and sales projections: - Infectious Diseases - Forensic Testing - Cancer - Paternity Testing/HLA Typing - Genetic Diseases - Others - A comprehensive analysis of the sequencing market by laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review - Comparison of the major molecular diagnosticanalyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom For more information visit http://www.researchandmarkets.com/research/kx...152019_u_s
SQNM: 2.13 (-0.03), MYGN: 38.46 (+0.07), A: 35.96 (+0.10), CPHD: 51.97 (+0.70), DHR: 86.84 (+0.79), HOLX: 40.11 (+0.72)
World Infectious Disease Molecular Diagnostics Market 2015-2019
M2 - Thu Jul 09, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c4c7sd/20152019_world) has announced the addition of the "2015-2019 World Infectious Disease Molecular Diagnostics Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies" report to their offering. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Report Highlights - Business and technological trends in major markets - Five-year test volume and sales forecasts - Market shares of leading competitors - Feature comparison of major analyzers - Strategic profiles of leading market players and start-up firms developing innovative products - Specific product and business opportunities for instrument and consumable suppliers. Worldwide Market Overview - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by country and market segment. - Five-year test volume and sales projections by country. Market Segmentation Analysis - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers by country. Product/Technology Review - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Cepheid - CellMark Forensics Lab/Corp - Decode Genetics - Diadexus - Grifols - Hologic/Gen-Probe Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/c4...2019_world
MYGN: 38.46 (+0.07), A: 35.96 (+0.10), DHR: 86.84 (+0.79), SQNM: 2.13 (-0.03), CPHD: 51.97 (+0.70), HOLX: 40.11 (+0.72)
